---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-082739"
form_type: "8-K"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2024-07-10T23:59:59+00:00"
generated_at: "2026-05-31T21:59:59.129737+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Eledon Pharmaceuticals completes $2.1M unregistered stock sale of 909,088 shares

## Summary
- Sold 909,088 shares of common stock in second closing under Securities Purchase Agreement dated April 28, 2023.
- Gross proceeds of approximately $2.1 million from institutional and accredited investors.
- Exempt from registration under Section 4(a)(2) and Rule 506(b).

## SEC filing metadata
- accession: 0000950170-24-082739
- form_type: 8-K
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2024-07-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000095017024082739/0000950170-24-082739-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000095017024082739/eldn-20240708.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-082739
- JSON: https://secwatch.observer/filing/0000950170-24-082739.json
- Plain text: https://secwatch.observer/filing/0000950170-24-082739.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.